Jpmorgan Chase & CO Iridex Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IRIX
# of Institutions
31Shares Held
3.3MCall Options Held
500Put Options Held
33.5K-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX1MShares$1.8 Million3.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$1.01 Million0.0% of portfolio
-
Amh Equity LTD501KShares$902,0171.21% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny397KShares$715,2480.0% of portfolio
-
Geode Capital Management, LLC Boston, MA131KShares$236,1090.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $28.8M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...